Multiply Labs and Wilson Wolf Collaborate to Automate G-Rex for Cell Therapy Manufacturing
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Wilson Wolf, an innovative leader in cell and gene-modified cell (CGT) manufacturing technology, today announced a collaboration around the automation of Wilson Wolf’s G-Rex® bioreactors.
AgonOx Cell Therapy Manufacturing Process Scientific Poster
Analytical Tools to Evaluate CAR-T Cell Signaling & Activation App Note
Fully Automated and Closed Cell Processing System for Large Scale Final Formulation, Fill and Finish of Engineered T-Cells
G-Rex: Expanding the Capabilities of Scalability
G-Rex® Fill-and-Forget Workflow Application Note
AgonOx Case Study - Elevating Customer Support
TcBuster transposase for robust delivery of multicistronic therapeutic cargo - Scientific Poster
Feeder-Free Human iNK Differentiation Process - Scientific Poster
Current iNK differentiation protocols typically utilize xenogenic feeder cells, which could be problematic for patient safety, or they lack robustness and are highly variable in differentiation efficiency. Using animal-free small molecules and recombinant proteins, Bio-Techne developed a feeder-free differentiation process to reliably generate iNKs at scale by optimizing for CD34+ hematopoietic stem cells (iHSC) prior to downstream NK differentiation.